Evaluation of polyethylene oxide compacts as gastroretentive delivery systems

AAPS PharmSciTech

Volumn 10, Issue 1, 2009, Pages 98-103

  Mahalingam, Ravichandran ^a   Jasti, Bhaskara ^a   Birudaraj, Raj ^b   Stefanidis, Dimitrios ^b   Killion, Robert ^b   Alfredson, Tom ^b   Anne, Pratap ^a   Li, Xiaoling ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

Bioadhesion; Compacts; Gastroretentive; Polyethylene oxide; Polyvinylpyrrolidone

Indexed keywords

DRUG; FILLER; MACROGOL; POLYMER; POVIDONE; WATER; COLORING AGENT; DRUG CARRIER; MACROGOL DERIVATIVE; METHYLENE BLUE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG ADSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RETENTION; DRUG SOLUBILITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; REACTION TIME; STOMACH ABSORPTION; STOMACH MUCOSA; SWINE; WATER ABSORPTION; ADHESION; ANIMAL; CHEMISTRY; DRUG DOSAGE FORM; EVALUATION; METABOLISM; METHODOLOGY; PHARMACEUTICS; SOLUBILITY; STOMACH;

ADHESIVENESS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; COLORING AGENTS; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; GASTRIC MUCOSA; MALE; METHYLENE BLUE; POLYETHYLENE GLYCOLS; POVIDONE; SOLUBILITY; STOMACH; SWINE; TECHNOLOGY, PHARMACEUTICAL;

EID: 67549108387     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9182-1     Document Type: Article

References (31)

1. J. Ali, S. Hasan, and M. Ali. Formulation and development of gastroretentive drug delivery system for ofloxacin. Methods Find. Exp. Clin. Pharmacol. 28(7):433-439 (2006).
2. J. Ali et al. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib. PDA J. Pharm. Sci. Technol. 61(2):88-96 (2007).
3. S. C. Basak, J. Rahman, and M. Ramalingam. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride. Pharmazie. 62(2):145-148 (2007).
4. S. Christensen. The biological fate of riboflavin in mammals. A survey of literature and own investigations. Acta Pharmacol. Toxicol. (Copenh). 32:3-72 (1973).
5. B. S. Dave, A. F. Amin, and M. M. Patel. Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation. AAPS PharmSciTech. 5(2):e34 (2004).
6. D. Deleu, G. Ebinger, and Y. Michotte. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa. Eur. J. Clin. Pharmacol. 41(5):453-458 (1991).
7. P. H. Marathe et al. Pharmacokinetics and bioavailability of a metformin/ glyburide tablet administered alone and with food. J. Clin. Pharmacol. 40(12 Pt 2):1494-1502 (2000).
8. S. S. Davis. Formulation strategies for absorption windows. Drug Discov. Today. 10(4):249-257 (2005).
9. A. J. Moes. Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier. Syst. 10(2):143-195 (1993).
10. A. Streubel, J. Siepmann, and R. Bodmeier. Gastroretentive drug delivery systems. Expert. Opin. Drug Deliv. 3(2):217-233 (2006).
11. A. Streubel, J. Siepmann, and R. Bodmeier. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr. Opin. Pharmacol. 6(5):501-508 (2006).
12. M. Jaimini, A. C. Rana, and Y. S. Tanwar. Formulation and evaluation of famotidine floating tablets. Curr. Drug Deliv. 4(1):51-55 (2007).
13. N. Rouge et al. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm. Acta Helv. 73(2):81-87 (1998).
14. A. Streubel, J. Siepmann, and R. Bodmeier. Floating microparticles based on low density foam powder. Int J Pharm. 241(2):279-92 (2002).
15. A. Streubel, J. Siepmann, and R. Bodmeier. Multiple unit gastroretentive drug delivery systems: A new preparation method for low density microparticles. J. Microencapsul. 20(3):329-347 (2003).
16. R. Talukder, and R. Fassihi. Gastroretentive delivery systems: Hollow beads. Drug Dev. Ind. Pharm. 30(4):405-412 (2004).
17. L. Whitehead et al. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J. Control Release. 55(1):3-12 (1998).
18. R. Groning, C. Cloer, and R. S. Muller. Development and in vitro evaluation of expandable gastroretentive dosage forms based on compressed collagen sponges. Pharmazie. 61(7):608-612 (2006).
19. R. Groning et al. Compressed collagen sponges as gastroretentive dosage forms: In vitro and in vivo studies. Eur. J. Pharm. Sci. 30(1):1-6 (2007).
20. E. A. Klausner et al. Expandable gastroretentive dosage forms. J. Control. Release. 90(2):143-162 (2003).
21. D. Duchene, and G. Ponchel. Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials. 13(10):709-714 (1992).
22. Y. Huang et al. Molecular aspects of muco- and bioadhesion: Tethered structures and site-specific surfaces. J. Control. Release. 65(1-2):63-71 (2000).
23. G. Ponchel, and J. Irache. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug. Deliv. Rev. 34(2-3):191-219 (1998).
24. S. L. Tao, and T. A. Desai. Gastrointestinal patch systems for oral drug delivery. Drug Discov. Today. 10(13):909-915 (2005).
25. C. Atuma et al. The adherent gastrointestinal mucus gel layer: Thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 280(5):G922-G929 (2001).
26. R. J. Bhaskara, et al. Effect of Polymer Swelling on Mucoadhesion in Various GI Locations. Controlled Release Society symposium, Hawaii. (2005).
27. R. L. Schmitt. Polyethylene oxide. In C R. Raymond, J. S. Paul, and J. W. Paul (eds.), Handbook of pharmaceutical excipients, 4th ed., Pharmaceutical Press and American Pharmaceutical Association, London, 2003, pp. 460-461.
28. G. V. Betageri, D.V. Deshmukh, and R. B. Gupta. Oral sustained-release bioadhesive tablet formulation of didanosine. Drug Dev. Ind. Pharm. 27(2):129-136 (2001).
29. A. H. Kibbe. Povidone. In C. R. Raymond, J. S. Paul, and J. W. Paul (eds.), Handbook of pharmaceutical excipients, 4th ed., Pharmaceutical Press and American Pharmaceutical Association, London, 2003, pp. 508-513.
30. W. Wessel, M. Schoog, and E. Winkler. Polyvinylpyrrolidone (PVP), its diagnostic, therapeutic and technical application and consequences thereof. Arzneimittelforschung. 21(10):1468-1482 (1971).
31. S. Y. Hou, V. E. Cowles, and B. Berner. Gastric retentive dosage forms: a review. Crit. Rev. Ther. Drug Carrier Syst. 20(6):459-597 (2003).